Vobarilizumab

DB14891Investigational

Vobarilizumab is under investigation in clinical trial NCT02101073 (ALX-0061 Phase I Bioavailability Study in Healthy Volunteers).

Mechanism: Pharmacologically active on Interleukin-6 receptor subunit alpha
Curator reviewed
Code names: ALX-0061

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

3Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Vobarilizumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.